TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15061993

Group type: EXPERIMENTAL
Intervention: rhTPO (1.0 microg.kg(‐1).d(‐1) administered subcutaneously 6‐24 hours after chemotherapy for up to 14 days)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: rhTPO
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control (non-rhTPO-treated cycle)
Number of subjects: 81
Study: 11568579

Group type: EXPERIMENTAL
Intervention: Tonsillectomy with argon plasma coagulation (TE(APC))
Number of subjects: 201

Group type: COMPARATOR
Intervention: Conventional tonsillectomy (TE(Conv))
Number of subjects: 201
Study: 9692103

Group type: EXPERIMENTAL
Intervention: Amoxycillin (500 mg t.d.s.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (500 mg b.d.)
Number of subjects: 12
Study: 7921859

Group type: EXPERIMENTAL
Intervention: Flumazenil (F)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 30
Study: 3167404

Group type: EXPERIMENTAL
Intervention: Clomipramine treatment with self-exposure instructions
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Therapist-aided exposure (1.3 hours) added to self-exposure instructions (3 hours) after 8 weeks
Number of subjects: 49
Study: 31575823

Group type: EXPERIMENTAL
Intervention: Deep friction massage (DFM) with varying pressures
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control session (no DFM)
Number of subjects: 10
Study: 30106637

Group type: EXPERIMENTAL
Intervention: HIMRT (72 Gy in 2.4 Gy fractions over 6 weeks)
Number of subjects: 206

Group type: COMPARATOR
Intervention: CIMRT (75.6 Gy in 1.8 Gy fractions over 8.4 weeks)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: HIMRT
Number of subjects: 206

Group type: COMPARATOR
Intervention: CIMRT
Number of subjects: 206
Study: 27777076

Group type: EXPERIMENTAL
Intervention: Talking Pill Bottles with antihypertensive medications and recordings of pharmacists' counseling
Number of subjects: 134

Group type: COMPARATOR
Intervention: Usual care instructions with antihypertensive medications
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Talking Pill Bottles
Number of subjects: 134
Study: 26277680

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU/month; n = 38)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Active placebo (400 IU vitamin E/month; n = 30)
Number of subjects: 68
Study: 24112259

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave lithotripsy (ESWL)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Ureterorenoscopic (URS) manipulation
Number of subjects: 190
Study: 20388201

Group type: EXPERIMENTAL
Intervention: Taxane-based chemotherapy (Carboplatin AUC5 and Docetaxel 75 mg/m2 administered intravenously in a 3-weekly schedule)
Number of subjects: 32
Study: 18160502

Group type: EXPERIMENTAL
Intervention: Percutaneous fixation with a cannulated Acutrak screw
Number of subjects: 60

Group type: COMPARATOR
Intervention: Immobilisation in a cast
Number of subjects: 60
Study: 16840728

Group type: EXPERIMENTAL
Intervention: Intensive induction and consolidation treatment according to a single protocol for patients above age 60
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: High-risk cytogenetics
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Age above 70 years
Number of subjects: 361
Study: 14564333

Group type: EXPERIMENTAL
Intervention: Heparin-coated stent
Number of subjects: 50

Group type: COMPARATOR
Intervention: Noncoated stent
Number of subjects: 50
Study: 11018621

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg, adjustable to 25 mg or 100 mg)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 254
Study: 9028183

Group type: EXPERIMENTAL
Intervention: Direct complete excavation
Number of subjects: 116

Group type: COMPARATOR
Intervention: Stepwise excavation
Number of subjects: 116
Study: 1631174

Group type: EXPERIMENTAL
Intervention: Potassium depletion treatment (KD0, KD1, KD2)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Potassium depletion treatment (KD2)
Number of subjects: 14
Study: 6386253

Group type: EXPERIMENTAL
Intervention: Dihydroquinidine (DQ) 300 mg t.i.d.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Disopyramide (D) 200 mg t.i.d.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30672383

Group type: EXPERIMENTAL
Intervention: rs3842761 GG genotype in PR group
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: rs4244809 GG genotype in PR group
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: rs4244809 GG genotype compared to AA genotype
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: rs3842761 GG/CC+CG in FIGO stage III‐IV
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: rs4244809 GG/AA+AG in FIGO stage III‐IV
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: rs3842761 GG/CC+CG in serous adenocarcinoma subgroup
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: rs4244809 GG/AA+AG in serous adenocarcinoma subgroup
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: rs7924316 GG/TT+TG in serous adenocarcinoma subgroup
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: TCT haplotype of rs3741206/rs3842761/rs7924316
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: TC haplotype of rs3741206/rs3842761
Number of subjects: 181
Study: 29413060

Group type: EXPERIMENTAL
Intervention: Brief Cognitive Behavioural Stress Management Programme (BCBSMP), 1 session per week for 7 weeks, each session lasting 120 minutes.
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 61
Study: 27059887

Group type: EXPERIMENTAL
Intervention: ixmyelocel-T
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 25266206

Group type: EXPERIMENTAL
Intervention: High-protein yogurt (14 g protein/25 g CHO/0 g fat)
Number of subjects: 20

Group type: COMPARATOR
Intervention: High-fat snacks (crackers and chocolate)
Number of subjects: 20
Study: 22892748

Group type: EXPERIMENTAL
Intervention: Vibringe sonic irrigation technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Side‐vented needle irrigation (SNI)
Number of subjects: 20
Study: 20160003

Group type: EXPERIMENTAL
Intervention: Prospective ECG-triggered CT angiography (100 kV)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Prospective ECG-triggered CT angiography (120 kV)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Retrospective ECG-gated helical CT angiography (100 kV)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Retrospective ECG-gated helical CT angiography (120 kV)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Prospective ECG-triggered CT angiography
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Both techniques (prospective and retrospective)
Number of subjects: 139
Study: 17319368

Group type: EXPERIMENTAL
Intervention: Adhesive resin cement (Chemiace II)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional glass-ionomer cement (Ketac-Cem)
Number of subjects: 60
Study: 15337553

Group type: EXPERIMENTAL
Intervention: Oral aloe vera gel
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 11136207

Group type: EXPERIMENTAL
Intervention: Depressive disorders (diagnosed using GMS-AGECAT)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Socio-demographic correlates and life events
Number of subjects: 1500
Study: 9647159

Group type: EXPERIMENTAL
Intervention: Magnesium hydroxide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 8024092

Group type: EXPERIMENTAL
Intervention: Bassini with absorbable sutures (polyglycolic acid)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Bassini with nonabsorbable sutures (polyester)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Shouldice with four rows of polypropylene sutures
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Shouldice with two rows of polypropylene sutures
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Shouldice technique
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Omitting permanent muscle sutures (groups A and D)
Number of subjects: 750
Study: 2642754

Group type: EXPERIMENTAL
Intervention: Lovastatin (40 mg/day)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Probucol (500 mg b.i.d.)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Lovastatin plus colestipol (10 g b.i.d.)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Lovastatin (80 mg/day) plus colestipol (10 g b.i.d.)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Lovastatin plus probucol
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Probucol
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 17
Study: 797258

Group type: EXPERIMENTAL
Intervention: Clofibrate
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Halofenate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Clofibrate and Halofenate
Number of subjects: 12
Study: 30744679

Group type: EXPERIMENTAL
Intervention: Edelvaiss® Multiline NEO device
Number of subjects: 280

Group type: COMPARATOR
Intervention: Standard infusion system
Number of subjects: 280
Study: 29042645

Group type: EXPERIMENTAL
Intervention: Intranasal insulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Water administration
Number of subjects: 0
Study: 26963178

Group type: EXPERIMENTAL
Intervention: Educational intervention addressing common prejudices via scientific evidence and prerecorded audio-testimony from PWS; duration: two 3-hr sessions a week apart
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 188
Study: 25086122

Group type: EXPERIMENTAL
Intervention: Compression using ankle injury stockings (AIS) plus an Aircast boot
Number of subjects: 90

Group type: COMPARATOR
Intervention: Tubigrip plus an Aircast boot
Number of subjects: 90
Study: 21800228

Group type: EXPERIMENTAL
Intervention: Cartoon-based hostile attributional bias measure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test-retest reliability trial of the adapted measure
Number of subjects: 0
Study: 19617456

Group type: EXPERIMENTAL
Intervention: Speed of processing intervention (vs. no-contact control)
Number of subjects: 2030

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 2030
Study: 17697100

Group type: EXPERIMENTAL
Intervention: Cholinesterase inhibitor therapy (ChEI)
Number of subjects: 28961
Study: 14995919

Group type: EXPERIMENTAL
Intervention: Acupuncture (n = 37), stimulated once or twice a week until delivery or complete recovery
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (n = 35), no sham stimulation
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Acupuncture (n = 37)
Number of subjects: 72
Study: 11994555

Group type: EXPERIMENTAL
Intervention: GPIIb/IIIa antagonist, orbofiban
Number of subjects: 1014
Study: 9871430

Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 10
Study: 7591344

Group type: EXPERIMENTAL
Intervention: Raising the drinking age laws in New York State in the 1980s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serial beginning drinkers
Number of subjects: 0
Study: 2334579

Group type: EXPERIMENTAL
Intervention: Antispasmodic (otilonium)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Tranquilizer (clobazam)
Number of subjects: 86
Study: 371737

Group type: EXPERIMENTAL
Intervention: Truncal vagotomy and pyloroplasty
Number of subjects: 149

Group type: COMPARATOR
Intervention: Highly selective vagotomy
Number of subjects: 149
Study: 31907854

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 30137547

Group type: EXPERIMENTAL
Intervention: Tofacitinib modified-release (MR) 11 mg once daily (QD)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Tofacitinib immediate-release (IR) 5 mg twice daily (BID)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Both formulations (MR and IR)
Number of subjects: 209
Study: 28012081

Group type: EXPERIMENTAL
Intervention: Arthroplasty
Number of subjects: 136

Group type: COMPARATOR
Intervention: Fusion
Number of subjects: 136
Study: 25830242

Group type: EXPERIMENTAL
Intervention: Nurse home visitation program
Number of subjects: 460

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 460
Study: 24216486

Group type: EXPERIMENTAL
Intervention: Interactive shared reading with a character that fits conceptually with carrots (rabbit)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Passive reading with a character that fits conceptually with carrots (rabbit)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Interactive shared reading with a character that does not fit conceptually with carrots (turtle)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Passive reading with a character that does not fit conceptually with carrots (turtle)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Baseline group (not exposed to the book)
Number of subjects: 104
Study: 22496156

Group type: EXPERIMENTAL
Intervention: Apheresis platelets
Number of subjects: 1272

Group type: EXPERIMENTAL
Intervention: ABO-identical platelets
Number of subjects: 1272

Group type: EXPERIMENTAL
Intervention: Platelets stored for 3 days
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Randomized dose strategy, platelet source, ABO compatibility, and duration of storage
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Overall platelet transfusion
Number of subjects: 1272
Study: 18815438

Group type: EXPERIMENTAL
Intervention: Mixed amphetamine salts-extended release (MAS XR) 50 mg/day
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Atomoxetine 80 mg/day
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 17522240

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abdominoperineal resection
Number of subjects: 0
Study: 16021360

Group type: EXPERIMENTAL
Intervention: 250 mcg IFNbeta‐1b every other day
Number of subjects: 695
Study: 12499477

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9810560

Group type: EXPERIMENTAL
Intervention: Antiphospholipid antibodies positivity in children with partial seizures
Number of subjects: 23
Study: 8702064

Group type: EXPERIMENTAL
Intervention: Continuous force (50 cN, reactivated weekly for 4 and 7 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Interrupted continuous force (50 cN, uncontrolled for 3 weeks, then passive for 1 week)
Number of subjects: 16
Study: 2618318

Group type: EXPERIMENTAL
Intervention: Ketamine hydrochloride anaesthesia applied intravenously
Number of subjects: 0

Group type: COMPARATOR
Intervention: Halothane inhalation anaesthesia in combination with nitrous oxide and oxygen
Number of subjects: 0
Study: 383272

Group type: EXPERIMENTAL
Intervention: 100 mg/m2 q 3 wk
Number of subjects: 113

Group type: COMPARATOR
Intervention: 200 mg/m2 q 6 wk
Number of subjects: 113
Study: 31218992

Group type: EXPERIMENTAL
Intervention: Endurance training program (12 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study: 27941245

Group type: EXPERIMENTAL
Intervention: Transfusion after 6 weeks of storage
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transfusion after 1 to 5 weeks of storage
Number of subjects: 60
Study: 25671254

Group type: EXPERIMENTAL
Intervention: Lenvatinib (24 mg per day in 28-day cycles)
Number of subjects: 392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study: 23083331

Group type: EXPERIMENTAL
Intervention: Plyometric exercise combined with high intensity weight training (90-95% of maximum muscle strength)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plyometric exercise combined with low intensity weight training (60% of maximum muscle strength)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 0
Study: 22267138

Group type: EXPERIMENTAL
Intervention: Medical appointment with educational intervention (Group B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine medical appointment (Group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 120
Study: 19231158

Group type: EXPERIMENTAL
Intervention: Elevated pretreatment neutrophil count (cut-off value 4500 mm(‐3))
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Low pretreatment neutrophil count (below 4500 mm(‐3))
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: High pretreatment neutrophil count (above 4500 mm(‐3))
Number of subjects: 388
Study: 16762345

Group type: EXPERIMENTAL
Intervention: Vitrification
Number of subjects: 508

Group type: COMPARATOR
Intervention: Slow-freezing
Number of subjects: 508
Study: 16938062

Group type: EXPERIMENTAL
Intervention: Cognitive impairment
Number of subjects: 1726

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 1726

Group type: EXPERIMENTAL
Intervention: Alcoholics Anonymous Involvement
Number of subjects: 1726
Study: 14646680

Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost once daily
Number of subjects: 268

Group type: COMPARATOR
Intervention: 0.5% timolol twice daily
Number of subjects: 268
Study: 10760337

Group type: EXPERIMENTAL
Intervention: bosentan (1 g twice daily; n = 18)
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo (n = 12)
Number of subjects: 30
Study: 9275638

Group type: EXPERIMENTAL
Intervention: Teprenone
Number of subjects: 98
Study: 1996894

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg daily for six days
Number of subjects: 121

Group type: COMPARATOR
Intervention: 0.2 mg/kg every 12 hours for three doses
Number of subjects: 121
Study: 6648735

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg/d
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg plus triamterene 50 mg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Amiloride hydrochloride 5 mg plus hydrochlorothiazide 50 mg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 50 mg/d
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Indapamide 2.5 mg/d
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 30792142

Group type: EXPERIMENTAL
Intervention: Procyanidin supplementation (100 mg during a meal)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (two capsules during a meal)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Iron-rich meal (43 mg of iron)
Number of subjects: 40
Study: 29258716

Group type: EXPERIMENTAL
Intervention: FreeStyle Libre
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Dexcom G4 Platinum
Number of subjects: 22

Group type: COMPARATOR
Intervention: Both sensors
Number of subjects: 22
Study: 28279994

Group type: EXPERIMENTAL
Intervention: PreHomeCare (early inhomecare with video consultations and mobile applications)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care (in-hospital consultations)
Number of subjects: 160
Study: 25544294

Group type: EXPERIMENTAL
Intervention: Lidocaine plus dexmedetomidine solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lidocaine solution
Number of subjects: 20
Study: 24064339

Group type: EXPERIMENTAL
Intervention: Exercise (60 min/day for 5 days/wk at ∼85% HRmax for 12 weeks)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 24
Study: 21443422

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (2 g twice a day for 90 days)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 18163521

Group type: EXPERIMENTAL
Intervention: Subcutaneous methotrexate (15 mg/week for 24 weeks)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Oral methotrexate (15 mg/week for 24 weeks)
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Subcutaneous methotrexate (15 mg/week switched to 20 mg/week for 8 weeks)
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Subcutaneous methotrexate (20 mg/week for 8 weeks)
Number of subjects: 375
Study: 16928786

Group type: EXPERIMENTAL
Intervention: Itraconazole 50 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Itraconazole 100 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (fexofenadine alone)
Number of subjects: 11
Study: 15319645

Group type: EXPERIMENTAL
Intervention: Omeprazole, amoxycillin and clarithromycin (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Omeprazole and 2 placebos (n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (triple treatment and placebo)
Number of subjects: 20
Study: 11007083

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX) treatment
Number of subjects: 0
Study: 9173954

Group type: EXPERIMENTAL
Intervention: CHO supplement (1 g/kg) immediately postexercise
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CHO supplement (1 g/kg) 1 h postexercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (Pl) immediately postexercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (Pl) 1 h postexercise
Number of subjects: 8
Study: 8141712

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK) with subcutaneous heparin
Number of subjects: 41021

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK) and intravenous heparin
Number of subjects: 41021

Group type: EXPERIMENTAL
Intervention: Accelerated tissue plasminogen activator (t‐PA) and intravenous heparin
Number of subjects: 41021

Group type: EXPERIMENTAL
Intervention: Combined SK and t‐PA
Number of subjects: 41021
Study: 3099002

Group type: EXPERIMENTAL
Intervention: Complex and elemental enteral formulas at infusion rates of 50 to 150 kcal/hr
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Complex and elemental enteral formulas at osmolalities of 325 to 690 mOsm/Kg of water
Number of subjects: 20
Study: 28728683

Group type: EXPERIMENTAL
Intervention: Conventional HF treatment combined with an individualized nutritional intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional HF treatment
Number of subjects: 120
Study: 27413123

Group type: EXPERIMENTAL
Intervention: Potassium gluconate (20, 40, 60 mEq K/d)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Unfried potatoes (20, 40, 60 mEq K/d)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: French fries (40 mEq K)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (0 mEq K/d)
Number of subjects: 35
Study: 25752116

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate cream combined with He-Ne laser irradiation treatment
Number of subjects: 200

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate cream treatment
Number of subjects: 200